WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the appointment of Charles R. Bridges, M.D., Sc.D., as Executive Vice President and Chief Scientific Officer. In this role Charles will lead the scientific and clinical development of the CorVista System for commercialization. “We are […]
Author: Ken Dropiewski
Foldax Appoints Scott Huennekens to Board of Directors
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced the appointment of medical device veteran Scott Huennekens as an independent member of the company’s board of directors. Huennekens possesses more than 30 years of experience in the medical device industry, leading high-profile companies through IPOs and acquisitions, and serving on the board […]
MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker
CLAMART, France, Jan. 16, 2022 /PRNewswire/ — MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently received PMDA Japanese regulation agency approval for its latest range of implantable pacemakers, Alizea. The devices are equipped with Bluetooth technology for streamlined remote monitoring when paired with MicroPort CRM’s […]
AtriAN Medical’s Clinical Data Highlighted at the 2022 AF Symposium
Pioneering cardiac autonomic pulsed field ablation (PFA) technology provides a unique option for enhancing the durability of AF ablation. GALWAY, Ireland, Jan. 17, 2022 /PRNewswire/ — Irish medical device company AtriAN Medical today announced that clinical data from it’s first-in-human study was presented at this years renowned Annual AF Symposium in New York City. […]
Getinge appoints Patricia Fitch as President North America Region
GOTHENBURG, Sweden, Jan. 17, 2022 /PRNewswire/ — Getinge appoints Patricia Fitch as President North America Region. Patricia succeeds Eric Honroth who has been appointed President Life Science at Getinge. Patricia Fitch joined Getinge in March 2021 as Vice President US Sales covering the Acute Care Therapies division. Patricia has more than 30 years of medical device experience, having held leadership […]
Elastrin Therapeutics Announces Newly Formed Scientific Advisory Board
GREENVILLE, S.C.–(BUSINESS WIRE)–Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation of its Scientific Advisory Board. The Board is comprised of leading industry and university experts in cardiovascular research and clinical development. Former […]
Getinge appoints Elin Frostehav as President Acute Care Therapies and Eric Honroth as President Life Science
GETINGE, Sweden, Jan. 17, 2022 /PRNewswire/ — Getinge appoints new Presidents for two business areas and members of the Executive team. Elin Frostehav is appointed President Acute Care Therapies and Eric Honroth President Life Science starting April 1, 2022. Elin Frostehav has been appointed President Acute Care Therapies and member of the Getinge Executive team. […]
Leader in Molecular Medicine Wants Nitric Oxide in the Hands of Every Person
CHICAGO, Jan. 17, 2022 (GLOBE NEWSWIRE) — Today, Dr. Nathan S. Bryan, world-renowned molecular medicine and nitric oxide expert and founder of Pneuma Nitric Oxide, LLC and Bryan Nitriceuticals, LLC, announced a partnership with Berkeley Life, a practitioner-exclusive nitric oxide nutraceutical brand. Dr. Bryan and Berkeley Life share a mission […]
Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technology for the Treatment of Coronary and Peripheral Artery Diseases
Complementary technology to orbital atherectomy expands CSI’s vessel prep market opportunity ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today it has made significant progress towards the commercialization of […]
Evasc Neurovascular Announces Enrollment of First Patient in the French eCLIPs™ Safety, Feasibility and Efficacy Study (EESIS-FR)
The objective of this study is to obtain data on the technical feasibility, safety, and efficacy of the second-generation eCLIPs products for the treatment of bifurcation aneurysms. VANCOUVER, British Columbia–(BUSINESS WIRE)–Evasc Neurovascular, a pioneer in the development of disruptive endovascular treatments for cerebral aneurysms, announced today the enrollment of the […]



